34 related articles for article (PubMed ID: 11313183)
1. Gene expression profiles in the cellular response to a multinuclear platinum complex.
Gatti L; Beretta GL; Carenini N; Corna E; Zunino F; Perego P
Cell Mol Life Sci; 2004 Apr; 61(7-8):973-81. PubMed ID: 15095017
[TBL] [Abstract][Full Text] [Related]
2. Conjugates Containing Two and Three Trithiolato-Bridged Dinuclear Ruthenium(II)-Arene Units as In Vitro Antiparasitic and Anticancer Agents.
Studer V; Anghel N; Desiatkina O; Felder T; Boubaker G; Amdouni Y; Ramseier J; Hungerbühler M; Kempf C; Heverhagen JT; Hemphill A; Ruprecht N; Furrer J; Păunescu E
Pharmaceuticals (Basel); 2020 Dec; 13(12):. PubMed ID: 33339451
[TBL] [Abstract][Full Text] [Related]
3. The optimal neoadjuvant treatment of locally advanced esophageal cancer.
van der Wilk BJ; Eyck BM; Lagarde SM; van der Gaast A; Nuyttens JJME; Wijnhoven BPL; van Lanschot JJB
J Thorac Dis; 2019 Apr; 11(Suppl 5):S621-S631. PubMed ID: 31080638
[TBL] [Abstract][Full Text] [Related]
4. Increased toxicity of a trinuclear Pt-compound in a human squamous carcinoma cell line by polyamine depletion.
Kjellström J; Oredsson SM; Wennerberg J
Cancer Cell Int; 2012 May; 12(1):20. PubMed ID: 22640800
[TBL] [Abstract][Full Text] [Related]
5. Thermodynamic stability and energetics of DNA duplexes containing major intrastrand cross-links of second-generation antitumor dinuclear Pt(II) complexes.
Florian J; Kasparkova J; Farrell NP; Brabec V
J Biol Inorg Chem; 2012 Feb; 17(2):187-96. PubMed ID: 21894503
[TBL] [Abstract][Full Text] [Related]
6. The polynuclear platinum BBR3610 induces G2/M arrest and autophagy early and apoptosis late in glioma cells.
Shingu T; Chumbalkar VC; Gwak HS; Fujiwara K; Kondo S; Farrell NP; Bogler O
Neuro Oncol; 2010 Dec; 12(12):1269-77. PubMed ID: 20713409
[TBL] [Abstract][Full Text] [Related]
7. Excursions in polynuclear platinum DNA binding.
Mangrum JB; Farrell NP
Chem Commun (Camb); 2010 Sep; 46(36):6640-50. PubMed ID: 20694266
[TBL] [Abstract][Full Text] [Related]
8. Combined action of the dinuclear platinum compound BBR3610 with the PI3-K inhibitor PX-866 in glioblastoma.
Gwak HS; Shingu T; Chumbalkar V; Hwang YH; DeJournett R; Latha K; Koul D; Alfred Yung WK; Powis G; Farrell NP; Bögler O
Int J Cancer; 2011 Feb; 128(4):787-96. PubMed ID: 20473884
[TBL] [Abstract][Full Text] [Related]
9. New approaches to pharmacotherapy of tumors of the nervous system during childhood and adolescence.
Schor NF
Pharmacol Ther; 2009 Apr; 122(1):44-55. PubMed ID: 19318043
[TBL] [Abstract][Full Text] [Related]
10. Pharmacotherapy for adults with tumors of the central nervous system.
Schor NF
Pharmacol Ther; 2009 Mar; 121(3):253-64. PubMed ID: 19091301
[TBL] [Abstract][Full Text] [Related]
11. Trans-platinum(II) complexes with cyclohexylamine as expectator ligand induce necrosis in tumour cells by inhibiting DNA synthesis and RNA transcription.
Cepero V; García-Serrelde B; Moneo V; Blanco F; González-Vadillo AM; Alvarez-Valdés A; Navarro-Ranninger C; Carnero A
Clin Transl Oncol; 2007 Aug; 9(8):521-30. PubMed ID: 17720655
[TBL] [Abstract][Full Text] [Related]
12. Polynuclear platinum anticancer drugs are more potent than cisplatin and induce cell cycle arrest in glioma.
Billecke C; Finniss S; Tahash L; Miller C; Mikkelsen T; Farrell NP; Bögler O
Neuro Oncol; 2006 Jul; 8(3):215-26. PubMed ID: 16723633
[TBL] [Abstract][Full Text] [Related]
13. Chemoresistance in human ovarian cancer: the role of apoptotic regulators.
Fraser M; Leung B; Jahani-Asl A; Yan X; Thompson WE; Tsang BK
Reprod Biol Endocrinol; 2003 Oct; 1():66. PubMed ID: 14609433
[TBL] [Abstract][Full Text] [Related]
14. The novel trinuclear platinum complex BBR3464 induces a cellular response different from cisplatin.
Servidei T; Ferlini C; Riccardi A; Meco D; Scambia G; Segni G; Manzotti C; Riccardi R
Eur J Cancer; 2001 May; 37(7):930-8. PubMed ID: 11313183
[TBL] [Abstract][Full Text] [Related]
15. Development of resistance to a trinuclear platinum complex in ovarian carcinoma cells.
Perego P; Gatti L; Righetti SC; Beretta GL; Carenini N; Corna E; Dal Bo L; Tinelli S; Colangelo D; Leone R; Apostoli P; Lombardi L; Beggiolin G; Piazzoni L; Zunino F
Int J Cancer; 2003 Jul; 105(5):617-24. PubMed ID: 12740909
[TBL] [Abstract][Full Text] [Related]
16. Differential recognition by the tumor suppressor protein p53 of DNA modified by the novel antitumor trinuclear platinum drug BBR3464 and cisplatin.
Kasparkova J; Fojta M; Farrell N; Brabec V
Nucleic Acids Res; 2004; 32(18):5546-52. PubMed ID: 15486204
[TBL] [Abstract][Full Text] [Related]
17. Differences in the cellular response and signaling pathways of cisplatin and BBR3464 ([[trans-PtCl(NH3)(2)]2mu-(trans-Pt(NH3)(2)(H2N(CH2)(6)-NH2)2)]4+) influenced by copper homeostasis.
Kabolizadeh P; Ryan J; Farrell N
Biochem Pharmacol; 2007 May; 73(9):1270-9. PubMed ID: 17234160
[TBL] [Abstract][Full Text] [Related]
18. Cisplatin and platinum drugs at the molecular level. (Review).
Boulikas T; Vougiouka M
Oncol Rep; 2003; 10(6):1663-82. PubMed ID: 14534679
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
